应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GCGR GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP
交易中 10-13 14:46:13 EDT
10.13
+0.00
0.00%
最高
10.13
最低
10.13
成交量
117.00
今开
10.13
昨收
10.13
日振幅
0.00%
总市值
4.68亿
流通市值
4.17亿
总股本
4,619万
成交额
1,181
换手率
0.00%
流通股本
4,116万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
礼来(LLY.US)三靶点激动剂公布III期数据
智通财经 · 09-30
礼来(LLY.US)三靶点激动剂公布III期数据
加载更多
公司概况
公司名称:
GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP
所属市场:
NASDAQ
上市日期:
--
主营业务:
General Catalyst Global Resilience Merger Corp.是一家空白支票公司,于2026年1月14日作为开曼群岛豁免公司注册成立,目的是与一项或多项业务进行合并、股份交换、资产收购、股份购买、重组或类似业务合并。
发行价格:
--
{"stockData":{"symbol":"GCGR","market":"US","secType":"STK","nameCN":"GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP","latestPrice":10.131,"timestamp":1791906698567,"preClose":10.131,"halted":0,"volume":117,"delay":0,"changeRate":0,"floatShares":41155000,"shares":46186200,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"10-13 14:46:13 EDT","open":10.131,"high":10.131,"low":10.131,"amount":1181.408787,"amplitude":0,"askPrice":10.17,"askSize":600,"bidPrice":10.08,"bidSize":418,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":10.131,"postHourTrading":{"tag":"盘后","latestPrice":10.131,"preClose":10.131,"latestTime":"19:30 EDT","volume":1,"amount":10.1426,"timestamp":1791847802060,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":8.671299},"requestUrl":"/m/hq/s/GCGR","defaultTab":"news","newsList":[{"id":"2671427645","title":"礼来(LLY.US)三靶点激动剂公布III期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2671427645","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671427645?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:19","pubTimestamp":1790752761,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,9月30日,礼来公布TRIUMPH-2研究的详细结果。TRIUMPH-2是一项III期临床研究,旨在在合并有2型糖尿病的肥胖或超重成人患者中评估retatrutide的有效性和安全性。Retatrutide是目前进展最快的GLP-1R/GIPR/GCGR激动剂。礼来计划于2027年第一季度向美国食品药品监督管理局提交生物制品许可申请。TRIUMPH-2研究中阻塞性睡眠呼吸暂停试验的更多研究结果将在未来的医学会议上公布,并发表于同行评议期刊。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4160","GCGR","GIPR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0058},{"period":"3month","weight":-0.0038},{"period":"6month","weight":0.0061},{"period":"ytd","weight":0.0061}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.0181},{"period":"3month","weight":0.0349},{"period":"6month","weight":0.1117},{"period":"1year","weight":0.1915},{"period":"ytd","weight":0.141}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"General Catalyst Global Resilience Merger Corp.是一家空白支票公司,于2026年1月14日作为开曼群岛豁免公司注册成立,目的是与一项或多项业务进行合并、股份交换、资产收购、股份购买、重组或类似业务合并。","exchange":"NASDAQ","name":"GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP","nameEN":"GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP(GCGR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP(GCGR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP,GCGR,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP股票,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP股票老虎,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP股票老虎国际,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP行情,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP股票行情,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP股价,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP股市,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP股票价格,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP股票交易,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP股票购买,GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP(GCGR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP(GCGR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}